Smithies O.Theodore Cooper Memorial Lecture.A mouse view of hypertension. Hypertension1997;30:1318-24.
2.
Smithies O., Kim HSTargeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA1994 ;91:3612-15.
3.
Smithies O., Maeda N.Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc Natl Acad Sci USA1995;92:5266-72.
4.
Carey RM, Wang ZQ, Siragy HMRole of the angiotensin type 2 receptor in the regulation of BP and renal function. Hypertension2000;35:155-63.
5.
Chung O., Unger T.Unopposed stimulation of the angiotensin AT2-receptor in the kidney [editorial] . Nephrology, Dialysis, Transplantation1998 ;13:537-40.
6.
Coffman TMGene targeting in physiological investigations: studies of the renin-angiotensin system. Am J Physiol1998;274:F999-1005.
7.
De Gasparo M. , Siragy HMThe AT2-receptor: fact, fancy and fantasy . Regulatory Peptides1999;81:11-24.
8.
Le TH, Coffman TMGenetic manipulation of the renin-angiotensin system. [Review] [75 refs]. Current Opinion Nephrol. Hypertension1999 ;8:397-403.
9.
Nishimura H., Ichikawa I.What have we learned from gene targeting studies for the renin angiotensin system of the kidney?Intern Med1999;38:315-23.
10.
De Gasparo M. , Catt KJ, Inagami T., Wright JW, Unger T.International union of pharmacology. XXIII. The Ang II receptors. Pharmacol Rev2000;52:415-72.
11.
Edwards RM, Aiyar N.Ang II receptor subtypes in the kidney. J Amer Soc Nephrol1993;3:1643-52.
12.
Timmermans Pbmwm , Wong PC, Chiu AT et al. Ang II receptors and Ang II receptor antagonists. Pharmacol Rev1993;45:205-51.
13.
Esther CR, Marino EM, Howard TE et al. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest1997; 99:2375-85.
14.
Kim HS, Krege JH, Kluckman KD et al. Genetic control of BP and the angiotensinogen locus. Proc Natl Acad Sci USA1995;92:2735-9.
15.
Krege JH, John SW, Langenbach LL et al. Male-female differences in fertility and BP in ACE-deficient mice. Nature1995;375:146-8.
16.
Krege JH, Kim HS, Moyer JS et al. Angiotensin-converting enzyme gene mutations, BP, and cardiovascular homeostasis. Hypertension1997;29:150-7.
17.
Murakami K. , Tanimoto K., Sugaya T., Fukamizu A.Hypertensive and hypotensive mice produced by the introduction and disruption of genes on the renin-angiotensin system . Blood Pressure1996;(Suppl) 2:36-40.
18.
Nimura F., Labosky PA, Kakuchi J. et al. Gene targeting reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth regulation. J Clin Invest1998; 96:2947-54.
19.
Tanimoto K. , Sugiyama F., Gotto Y. et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem1994;269: 31334-7.
20.
Gomez RARole of angiotensin in renal vascular development. Kidney Interna1998;(Suppl) 67:S12-S16.
21.
Guron G.,Friberg P.An intact renin-angiotensin system is a prerequisite for normal renal development . J Hypertension2000;18:123-37.
22.
Hilgers KF, Norwood VF, Gomez RAAngiotensin's role in renal development. Seminars Nephrol1997;17:492-501.
23.
Kihara M., Umemura S., Kadota T. et al. The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene-knockout mice. Lab Invest1997;76:285-94.
24.
Kihara M., Umemura S., Sumida Y. et al. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice. Kidney Internat1998;53:548-55.
25.
Okubo S., Niimura F., Matsusaka T., Fogo A., Hogan BL, Ichikawa I.Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption.Kidney Internat1998;53:617-25.
26.
Kim HS, Maeda N., Oh GT, Fernandez LG, Gomez RA, Smithies O.Homeostasis in mice with genetically decreased angiotensinogen is primarily by an increased number of renin-producing cells. J Biol Chem1999;274:14210-7.
27.
Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KEMice lacking angiotensin-converting enzyme have low BP, renal pathology, and reduced male fertility. Lab Invest1996;74:953-65.
28.
Ito M., Oliverio MI, Mannon PJ et al. Regulation of BP by the type 1A Ang II receptor gene. Proc Natl Acad Sci USA1995;92:3521-5.
29.
Matsusaka T. , Nishimura H., Utsunomiya H. et al. Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest1996 ;98:1867-77.
30.
Inokuchi S. , Kimura K., Sugaya T. et al.Ang II maintains the structure and function of glomerular mesangium via type 1a receptor. What we have learned from null mutant mice minus the Ang II type 1a receptor gene. Virchows Archiv1998;433:349-57.
31.
Sugaya T., Nishimatsu S., Tanimoto K. et al. Ang II type 1a receptor deficient mice with hypotension and hyperreninemia. J Biol Chem1995;270:18719-22.
32.
Oliverio MI , Best CF, Kim HS,Arendshorst WJ, Smithies O., CoffmanTM.Ang II responses in AT1A receptor-deficient mice: a role for AT1B receptors in BP regulation. Am J Physiol1997;272:F515-F520.
33.
Zhu Z., Zhang SH,Wagner C. et al.Angiotensin AT1B receptor mediates calcium signaling in vascular smooth muscle cells of AT1A receptor-deficient mice. Hypertension1998;31:1171-7.
34.
Cervenka L. , Mitchell KD, Oliverio MI, Coffman TM, Navar LGRenal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Inter1999;56:1855-62.
35.
Meneton P., Ichikawa I., Inagami T., Schnermann J.Renal physiology of the mouse. Am J Physiol2000;278: F339-F351.
36.
Harrison-Bernard LM, Cook AK, Oliverio MI, Coffman TM, Navar LGAfferent arteriolar diameter responses to Ang II in AT1A receptor deficient mice. FASEB J2000;14:A135. (Abstract).
37.
Ruan X., Oliverio MI,Coffman TM, Arendshorst WJRenal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice. J Am Soc Nephrol1999;10:2620-30.
38.
Harrison-Bernard LM, Cook AK, Oliverio MI, Coffman TM, Navar LGLack of efferent arteriolar diameter responses to Ang II in AT1A deficient mice. FASEB J2001;15:A149 (Abstract).
39.
Kimura K., Inokuchi S., Sugaya T. et al. Location and action of Ang II type 1 receptor in the renal microcirculation . Kidney Internat1997;(Suppl) 63: S201-S204.
40.
Schnermann J.Micropuncture analysis of tubuloglomerular feedback regulation in transgenic mice. J Am Soc Nephrol1999;10:2614-9.
41.
Schnermann J., Traynor T., Yang T. et al. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am J Physiol1997;273:F315-F320.
42.
Traynor TR,Yang T., Huang YG et al. Tubuloglomerular feedback in ACE-deficient mice. Am J Physiol1999;276: F751-F757.
43.
Oliverio MI , Best CF, Smithies O., Coffman TMRegulation of sodium balance and BP by the AT(1A) receptor for Ang II. Hypertension2000 ;35:550-4.
44.
Oliverio MI , Delnomdedieu M., Best CF et al. Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. Am J Physiol2000;278:F75-F82.
45.
Chen X., Li W., Yoshida H. et al. Targeting deletion of angiotensin type 1B receptor gene in the mouse.AmJPhysiol1997;272:F299-F304,
46.
Oliverio MI , Kim HS, Ito M. et al. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated BP regulation in mice lacking both AT1A and AT1B receptors for Ang II. Proc Natl Acad Sci USA1998;95:15496501.
47.
Tsuchida S. , Matsusaka T., Chen X. et al. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest1998;101:755-60.
48.
Siragy HM, Carey RMThe subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats [see comments]. J Clin Invest1996;97:1978-82.
49.
Siragy HM, Inagami T., Ichiki T., Carey RMSustained hypersensitivity to Ang II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA1999;96:6506-10.
50.
Liu KL, Lo M., Grouzmann E., Mutter M., Sassard J.The subtype 2 of Ang II receptors and pressure-natriuresis in adult rat kidneys . Brit J Pharmacol1999;126:826-32.
51.
Lo M., Liu KL, Lantelme P., Sassard J.Subtype 2 of Ang II receptors controls pressure-natriuresis in rats. J Clin Invest1995;95:1394-7.
52.
Hein L., Barsh GS, Pratt RE, Dzau VJ, Kobilka BKBehavioral and cardiovascular effects of disrupting the Ang II type-2 receptor in mice.Nature (Lond.)1995;377:744-7.
53.
Ichiki T., Labosky PA, Shiota C. et al. Effect on BP and exploratory behaviour of mice lacking Ang II type-2 receptor. Nature (London)1995;377:748-50.
54.
Nishimura H. , Yerkes E., Hohenfellner K. et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Molecular Cell1999;3:1-10.
55.
Akishita M. ,Yamada H., Dzau VJ, Horiuchi M.Increased vasoconstrictor response of the mouse lacking Ang II type 2 receptor. Biochem Biophysical Res Commun1999;261:345-9.
56.
Gross V., Francha Milia A., Phelm R., Inagami T., Luft FCLong-term blood pressure telemetry in AT2-receptor disrupted mice. J Hyperten2000;18:955-61.
57.
Tanaka M., Tsuchida S., Imai T. et al. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem Biophys Res Commun1999;258:194-8.
58.
HunleyTE,Tamura M., Stoneking BJ et al. The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice. Kidney Internat2000;57:570-7.
59.
Tsutsumi Y., Matsubara H., Masaki H. et al. Ang II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation [see comments]. J Clin Invest1999;104:925-35.
60.
Gross V., Schunck WH, Honeck H. et al. Inhibition of pressure natriuresis in mice lacking the AT2-receptor . Kidney Internat2000;57:191-202.
61.
Arima S., Endo Y., Yaoita H. et al. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of Ang II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest1997;100:2816-23.
62.
Endo Y., Arima S., Yaoita H. et al. Function of Ang II type 2 receptor in the postglomerular efferent arteriole. Kidney Internat1997;63:S205-S207.
63.
Chatziantoniou C., Arendshorst WJAngiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol1993;265:F853-F862.
